Rhoen Klinikum AG
SWB:RHK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Rhoen Klinikum AG
SWB:RHK
|
DE |
|
CNNC Hua Yuan Titanium Dioxide Co Ltd
SZSE:002145
|
CN |
|
S
|
Sanofi SA
XMUN:SNW
|
FR |
|
V
|
Vibrant Global Capital Ltd
BSE:538732
|
IN |
|
Hydrix Ltd
ASX:HYD
|
AU |
Wall Street
Price Targets
RHK Price Targets Summary
Rhoen Klinikum AG
According to Wall Street analysts, the average 1-year price target for
RHK
is 14.12 EUR
with a low forecast of 12.33 EUR and a high forecast of 16.41 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is RHK's stock price target?
Price Target
14.12
EUR
According to Wall Street analysts, the average 1-year price target for
RHK
is 14.12 EUR
with a low forecast of 12.33 EUR and a high forecast of 16.41 EUR.
What is Rhoen Klinikum AG's Revenue forecast?
Projected CAGR
6%
For the last 13 years the
compound annual growth rate for
Rhoen Klinikum AG's revenue is
-4%.
The projected
CAGR
for the next 4 years is
6%.
What is Rhoen Klinikum AG's Operating Income forecast?
Projected CAGR
13%
For the last 13 years the
compound annual growth rate for
Rhoen Klinikum AG's operating income is
-11%.
The projected
CAGR
for the next 4 years is
13%.
What is Rhoen Klinikum AG's Net Income forecast?
Projected CAGR
11%
For the last 13 years the
compound annual growth rate for
Rhoen Klinikum AG's net income is
-9%.
The projected
CAGR
for the next 4 years is
11%.
